Lower adalimumab trough levels are associated with higher bowel wall thickness in Crohn's disease

BACKGROUND: In Crohn's disease, higher adalimumab trough levels and negative anti-adalimumab-antibodies associate with better clinical and endoscopic outcomes. Intestinal ultrasound has become a relevant non-invasive method to monitor treatment. However, data on the association between adalimum...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:United European Gastroenterol J
Hlavní autoři: Ungar, Bella, Ben-Shatach, Zohar, Selinger, Limor, Malik, Alona, Albshesh, Ahmad, Ben-Horin, Shomron, Eliakim, Rami, Kopylov, Uri, Carter, Dan
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2019
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7079273/
https://ncbi.nlm.nih.gov/pubmed/32213067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640619878974
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky